CD36 and metabolic dysfunction-associated steatotic liver disease: Interestingly, by targeting liver HSC cells in nonalcoholic fatty liver disease, previous studies suggested that CD36 is related to liver cirrhosis and might promote fibrosis (Lin et al., 2019).